Best of PCR e-Course 2020
In case you missed, watch recordings of LAA Closure, Mitral, TAVI and Tricuspid late breaking trials and scientific sponsored sessions.
HOTLINE LATE-BREAKING TRIALS
Scientific Sponsored sessions
Chair U. Landmesser Discussants S. Windecker, D. Hildick-Smith
Attend this session if you want:
- To learn about which patients may benefit from LAA occlusion vs. long term anticoagulation
- To learn about the latest data of LAAO vs. NOACs from a substantial cohort in a propensity score matched study
Agenda:
Introduction and session objectives (U. Landmesser)
Moderated discussion (S. Windecker, D. Hildick-Smith)
- Unmet need: Alternative to medical therapy (long-term NOAC therapy)
- What does the latest data tell us: Results from a propensity score matched follow-up study based on the Amulet Observational registry
- Immediate impact: LAA occlusion viable alternative to OAC including NOACs, this to be confirmed in future trials
- Outlook: Catalyst trial evaluating safety and effectiveness of Amulet compared to NOAC therapy in patients with non-valvular AF at increased risk for ischemic stroke and systemic embolism, and who are recommended for long-term NOAC therapy
Key Learnings (U. Landmesser)
Chair F. Maisano Discussants S. Kar, M. Sitges
Attend this session if you want:
- To tailor the mitral valve repair and optimize treatment based on etiology and mitral valve anatomy
- To learn about current MitraClip clip options as well as look in the future of the mitral repair treatment
Agenda:
Session objectives
F. MaisanoLearnings from Largest Contemporary Real-World, All Comer Mitral Repair Outcomes
Dr. KarTailoring Mitral Valve Repair: Evidence based recommendation for Clip selection
F. MaisanoImportance of appropriate mitral valve leaflet visualization for outcomes
M. SitgesWhat does the mitral valve repair future hold?
S. KarSession Learnings
F. MaisanoChair N. Dumonteil Discussants A. Duncan, L. Conradi
Attend this session if you want:
- To learn about the latest update on Tendyne TMVI clinical experience
- To learn about which patients may benefit from this novel therapeutical option
Agenda:
Introduction and session objectives (N. Dumonteil)
What is Tendyne TMVI and current clinical experience (N. Dumonteil)
- Echo screening (A. Duncan)
- CT screening (L. Conradi)
- First commercial cases overview (L. Conradi)
Discussion and key learnings (N. Dumonteil)
Chair L. Sondergaard Discussants H. Möllmann, M. Mullen
Attend this session if you want:
- To learn more about the new Portico with FlexNav TAVI system and its industry leading deliverability
- To learn how Portico enables you to achieve excellent hemodynamics and patient outcomes
- To learn importance of “looking ahead” during TAVI and ensuring patients coronary access preservation
Agenda:
Session objectives (L. Sondergaard)
Portico with FlexNav latest clinical evidence & procedural benefits (H. Möllmann)
Innovation at its best, new Portico with FlexNav TAVI System (M. Mullen)
Portico with FlexNav Procedural Highlights (L. Sondergaard)
Session Learnings (L. Sondergaard)
Chair G. Nickenig Discussants S. von Bardeleben, F. Praz
Attend this session if you want:
- To learn why diagnosis and treatment of tricuspid regurgitation is the next transcatheter valvular treatment frontier
- To learn more about TriClip, novel therapy option for patients suffering from TR
- To learn about patient selection and ensure procedural success
Agenda:
Session objectives (G. Nickenig)
Tricuspid Regurgitation, disease burden and necessity for treatment (F. Praz)
TriClip dedicated treatment option for patients with Tricuspid Regurgitation (G. Nickenig)
Overview of the TriClip procedure (S. von Bardeleben)
Key Learnings (G. Nickenig)
Sign Up
Register to stay updated on latest news about Mitral Regurgitation , Aortic Stenosis, Heart Failure management and Stroke Prevention
Register nowUnless otherwise specified, all product and service names appearing herein are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name or trade dress may be made without their prior written authorization of Abbott. Products intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use provided inside the product carton (when available) or at eifu.abbottvascular.com or at medical.abbott/manuals for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events. All drawings are artist's representations only and should not be considered as engineering drawings or photographs. Photo(s) on file at Abbott. Information contained herein is for distribution for Europe, Middle East and Africa ONLY. Please check the regulatory status of the device before distribution in areas where CE marking is not the regulation in force.
Abbott International BVBA, Park Lane, Culliganlaan 2b, 1831 Diegem, Belgium, tel: +32 2 714 14 11
© 2020 Abbott. All rights reserved. 9-EH-5-11308-01 07-2020 REV A.